Population is 11.4 million, the most populated Caribbean country.

The regulatory authority, CECMED, has among the most stringent registration requirements relative to semi-regulated countries in the region.

100% government market. No material private market but Alfarma is well positioned to adapt to any market changes and reforms.

Early adopter of high technology products relative to semi-regulated countries in the region.

Many Cuban physicians on contract in neighboring countries, extending Cuba’s leadership and influence in regional healthcare.

Manufacture many pharmaceuticals in Cuba for both domestic consumption and export.

Have partnerships with private foreign companies for biological products.

Why Alfarma

The Cuban market is extremely complex to navigate, and is poised for potential reforms and changes, that will require an experienced partner.
Read More


Calle 26 #121 entre 1ra y 3ra | Miramar Playa | Havana | Cuba 11300 | info@alfarma.net
Follow Us
Read More